UBS Maintains a 'Neutral' on Monsanto (MON); Highlights From Corn Belt Seed Conference
Tweet Send to a FriendGet Alerts MON Hot Sheet
Price: $108.65 +0.25%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 35 | New: 12
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 35 | New: 12
Trade MON Now!
UBS maintains a 'Neutral' on Monsanto (NYSE: MON) price target raised from $72 to $80.
UBS analyst says, "CRW (corn root worm) resistance highlighted: In attending the Corn Belt Seed Conference in Indiana last week, Purdue University entomologists discussed CRW resistance to Cry3Bb1. Interpreting their presentation, resistance is not a major issue today, but it is not going away and it is something that must be more effectively managed."
"Based on our informal survey of conference attendees, it appears seed suppliers are trimming discounts this year because of the continued strong farm economy, and on the margin, seed availability. Consequently, we believe price realizations will be greater than most investors expect, leading to more EPS surprises in F12. We remain at $3.60 and expect MON to beat consensus of $3.50."
For an analyst ratings summary and ratings history on Monsanto click here. For more ratings news on Monsanto click here.
Shares of Monsanto closed at $79.01 yesterday, with a 52 week range of $59.09-$83.94.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
UBS analyst says, "CRW (corn root worm) resistance highlighted: In attending the Corn Belt Seed Conference in Indiana last week, Purdue University entomologists discussed CRW resistance to Cry3Bb1. Interpreting their presentation, resistance is not a major issue today, but it is not going away and it is something that must be more effectively managed."
"Based on our informal survey of conference attendees, it appears seed suppliers are trimming discounts this year because of the continued strong farm economy, and on the margin, seed availability. Consequently, we believe price realizations will be greater than most investors expect, leading to more EPS surprises in F12. We remain at $3.60 and expect MON to beat consensus of $3.50."
For an analyst ratings summary and ratings history on Monsanto click here. For more ratings news on Monsanto click here.
Shares of Monsanto closed at $79.01 yesterday, with a 52 week range of $59.09-$83.94.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
